Lustgarten Foundation Archive — Page 1 of 1

Laboratory pipette dispensing an amber liquid into a clear multiwell test plate, with a blurred chemical structure in the background.
March 28, 2019

Cancer’s SOS

Stephen Fesik and colleagues are advancing cancer drug discovery with the characterization of small molecules that modulate RAS, an important target for anti-cancer therapies.

By Sanjay Mishra
Fluorescence microscopy image showing pancreatic tissue structures against a black background, with cells highlighted in blue, red, and green.
January 29, 2015

Grant bolsters pancreatic cancer drug discovery efforts

The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer.

By Vanderbilt Health News
March 13, 2014

A new way to target cancer-driver Ras

Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way.

By Leigh MacMillan